Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients

NCT06228092 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Neuromuscular Blockade, Residual

Interventions

DRUG: neostigmine/glycopyrrolate
DRUG: Sugammadex

Sponsor

Matias Vested